Outpatient parenteral antimicrobial therapy (OPAT) using a continuous ambulatory delivery device (CADD) allowing treatment with multiple daily doses: a brief report of a Norwegian experience

Background Outpatient parenteral antimicrobial therapy (OPAT) is safe, effective and increasingly available. While OPAT in Norwegian healthcare has been rare, a new continuous ambulatory delivery device (CADD) allowing multiple daily dosing treatments has been innovated making OPAT more accessible....

Full description

Saved in:
Bibliographic Details
Main Authors: Skogen, Vegard, Helleren, Rita, Jacobsen, Marianne Giske, Opsal, Anne, Gallefoss, Frode
Format: Article
Language:English
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Skogen, Vegard
Helleren, Rita
Jacobsen, Marianne Giske
Opsal, Anne
Gallefoss, Frode
description Background Outpatient parenteral antimicrobial therapy (OPAT) is safe, effective and increasingly available. While OPAT in Norwegian healthcare has been rare, a new continuous ambulatory delivery device (CADD) allowing multiple daily dosing treatments has been innovated making OPAT more accessible. Objectives To describe the clinical outcome and safety using CADD in an OPAT setting. Methods Adult patients in need of parenteral antibiotic treatment were offered OPAT and discharged with a programmable digital infusion pump allowing multiple daily dosings. Results Altogether, 170 patients were included in the study, among which 21% of all patients (36 of 170) were readmitted to hospital while receiving OPAT or within 30 days after end of intravenous antibiotics. None of the 170 patients died due to OPAT and allergies were not noticeable as a problem. Conclusions We have developed a safe and clinically effective programme offering OPAT in accordance with Norwegian antibiotic treatment guidelines.
format article
fullrecord <record><control><sourceid>cristin_3HK</sourceid><recordid>TN_cdi_cristin_nora_11250_3170582</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>11250_3170582</sourcerecordid><originalsourceid>FETCH-cristin_nora_11250_31705823</originalsourceid><addsrcrecordid>eNqNTjtuAkEM3SZFlOQOpoMiEgtCoHQIEqUKFPQr7-AFS7PjkcfDhsvlbBkiDpDqPb-P7cfqZ5ctojEFg4hagBQ9YDDu2am0XCY7FzFeYbzbrw8TyInDCRCclFTIkhNg32aPJnqFI3m-0B-5sCMYb9bb7QTQexluPVNC62_3BrYz9NkbR09wRPalJInSW1neKlMHSlHUQLqifIkOdGIMQN-Rih0cPVcPHfpEL3d8qkYf74fN56tTTuW5JohiU9ezxbSZ18vpYjWb_yfzC64TX6A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Outpatient parenteral antimicrobial therapy (OPAT) using a continuous ambulatory delivery device (CADD) allowing treatment with multiple daily doses: a brief report of a Norwegian experience</title><source>NORA - Norwegian Open Research Archives</source><creator>Skogen, Vegard ; Helleren, Rita ; Jacobsen, Marianne Giske ; Opsal, Anne ; Gallefoss, Frode</creator><creatorcontrib>Skogen, Vegard ; Helleren, Rita ; Jacobsen, Marianne Giske ; Opsal, Anne ; Gallefoss, Frode</creatorcontrib><description>Background Outpatient parenteral antimicrobial therapy (OPAT) is safe, effective and increasingly available. While OPAT in Norwegian healthcare has been rare, a new continuous ambulatory delivery device (CADD) allowing multiple daily dosing treatments has been innovated making OPAT more accessible. Objectives To describe the clinical outcome and safety using CADD in an OPAT setting. Methods Adult patients in need of parenteral antibiotic treatment were offered OPAT and discharged with a programmable digital infusion pump allowing multiple daily dosings. Results Altogether, 170 patients were included in the study, among which 21% of all patients (36 of 170) were readmitted to hospital while receiving OPAT or within 30 days after end of intravenous antibiotics. None of the 170 patients died due to OPAT and allergies were not noticeable as a problem. Conclusions We have developed a safe and clinically effective programme offering OPAT in accordance with Norwegian antibiotic treatment guidelines.</description><language>eng</language><publisher>Oxford University Press</publisher><creationdate>2024</creationdate><rights>info:eu-repo/semantics/openAccess</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktorsrc>$$Uhttp://hdl.handle.net/11250/3170582$$EView_record_in_NORA$$FView_record_in_$$GNORA$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Skogen, Vegard</creatorcontrib><creatorcontrib>Helleren, Rita</creatorcontrib><creatorcontrib>Jacobsen, Marianne Giske</creatorcontrib><creatorcontrib>Opsal, Anne</creatorcontrib><creatorcontrib>Gallefoss, Frode</creatorcontrib><title>Outpatient parenteral antimicrobial therapy (OPAT) using a continuous ambulatory delivery device (CADD) allowing treatment with multiple daily doses: a brief report of a Norwegian experience</title><description>Background Outpatient parenteral antimicrobial therapy (OPAT) is safe, effective and increasingly available. While OPAT in Norwegian healthcare has been rare, a new continuous ambulatory delivery device (CADD) allowing multiple daily dosing treatments has been innovated making OPAT more accessible. Objectives To describe the clinical outcome and safety using CADD in an OPAT setting. Methods Adult patients in need of parenteral antibiotic treatment were offered OPAT and discharged with a programmable digital infusion pump allowing multiple daily dosings. Results Altogether, 170 patients were included in the study, among which 21% of all patients (36 of 170) were readmitted to hospital while receiving OPAT or within 30 days after end of intravenous antibiotics. None of the 170 patients died due to OPAT and allergies were not noticeable as a problem. Conclusions We have developed a safe and clinically effective programme offering OPAT in accordance with Norwegian antibiotic treatment guidelines.</description><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>3HK</sourceid><recordid>eNqNTjtuAkEM3SZFlOQOpoMiEgtCoHQIEqUKFPQr7-AFS7PjkcfDhsvlbBkiDpDqPb-P7cfqZ5ctojEFg4hagBQ9YDDu2am0XCY7FzFeYbzbrw8TyInDCRCclFTIkhNg32aPJnqFI3m-0B-5sCMYb9bb7QTQexluPVNC62_3BrYz9NkbR09wRPalJInSW1neKlMHSlHUQLqifIkOdGIMQN-Rih0cPVcPHfpEL3d8qkYf74fN56tTTuW5JohiU9ezxbSZ18vpYjWb_yfzC64TX6A</recordid><startdate>2024</startdate><enddate>2024</enddate><creator>Skogen, Vegard</creator><creator>Helleren, Rita</creator><creator>Jacobsen, Marianne Giske</creator><creator>Opsal, Anne</creator><creator>Gallefoss, Frode</creator><general>Oxford University Press</general><scope>3HK</scope></search><sort><creationdate>2024</creationdate><title>Outpatient parenteral antimicrobial therapy (OPAT) using a continuous ambulatory delivery device (CADD) allowing treatment with multiple daily doses: a brief report of a Norwegian experience</title><author>Skogen, Vegard ; Helleren, Rita ; Jacobsen, Marianne Giske ; Opsal, Anne ; Gallefoss, Frode</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-cristin_nora_11250_31705823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Skogen, Vegard</creatorcontrib><creatorcontrib>Helleren, Rita</creatorcontrib><creatorcontrib>Jacobsen, Marianne Giske</creatorcontrib><creatorcontrib>Opsal, Anne</creatorcontrib><creatorcontrib>Gallefoss, Frode</creatorcontrib><collection>NORA - Norwegian Open Research Archives</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Skogen, Vegard</au><au>Helleren, Rita</au><au>Jacobsen, Marianne Giske</au><au>Opsal, Anne</au><au>Gallefoss, Frode</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outpatient parenteral antimicrobial therapy (OPAT) using a continuous ambulatory delivery device (CADD) allowing treatment with multiple daily doses: a brief report of a Norwegian experience</atitle><date>2024</date><risdate>2024</risdate><abstract>Background Outpatient parenteral antimicrobial therapy (OPAT) is safe, effective and increasingly available. While OPAT in Norwegian healthcare has been rare, a new continuous ambulatory delivery device (CADD) allowing multiple daily dosing treatments has been innovated making OPAT more accessible. Objectives To describe the clinical outcome and safety using CADD in an OPAT setting. Methods Adult patients in need of parenteral antibiotic treatment were offered OPAT and discharged with a programmable digital infusion pump allowing multiple daily dosings. Results Altogether, 170 patients were included in the study, among which 21% of all patients (36 of 170) were readmitted to hospital while receiving OPAT or within 30 days after end of intravenous antibiotics. None of the 170 patients died due to OPAT and allergies were not noticeable as a problem. Conclusions We have developed a safe and clinically effective programme offering OPAT in accordance with Norwegian antibiotic treatment guidelines.</abstract><pub>Oxford University Press</pub><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_cristin_nora_11250_3170582
source NORA - Norwegian Open Research Archives
title Outpatient parenteral antimicrobial therapy (OPAT) using a continuous ambulatory delivery device (CADD) allowing treatment with multiple daily doses: a brief report of a Norwegian experience
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-03-05T21%3A39%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-cristin_3HK&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outpatient%20parenteral%20antimicrobial%20therapy%20(OPAT)%20using%20a%20continuous%20ambulatory%20delivery%20device%20(CADD)%20allowing%20treatment%20with%20multiple%20daily%20doses:%20a%20brief%20report%20of%20a%20Norwegian%20experience&rft.au=Skogen,%20Vegard&rft.date=2024&rft_id=info:doi/&rft_dat=%3Ccristin_3HK%3E11250_3170582%3C/cristin_3HK%3E%3Cgrp_id%3Ecdi_FETCH-cristin_nora_11250_31705823%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true